1. Home
  2. GPCR vs MC Comparison

GPCR vs MC Comparison

Compare GPCR & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

N/A

Current Price

$16.13

Market Cap

3.8B

Sector

N/A

ML Signal

N/A

Logo Moelis & Company

MC

Moelis & Company

N/A

Current Price

$51.35

Market Cap

4.1B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
GPCR
MC
Founded
2016
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.1B
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
GPCR
MC
Price
$16.13
$51.35
Analyst Decision
Strong Buy
Hold
Analyst Count
16
11
Target Price
★ $104.86
$65.70
AVG Volume (30 Days)
829.6K
★ 938.0K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
★ 4.86%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.75
Revenue
N/A
N/A
Revenue This Year
N/A
$11.60
Revenue Next Year
N/A
$19.00
P/E Ratio
★ N/A
$71.36
Revenue Growth
N/A
N/A
52 Week Low
$16.88
$51.06
52 Week High
$94.90
$78.22

Technical Indicators

Market Signals
Indicator
GPCR
MC
Relative Strength Index (RSI) 22.78 32.85
Support Level N/A $51.61
Resistance Level $22.54 $70.99
Average True Range (ATR) 1.42 2.34
MACD 0.03 -0.51
Stochastic Oscillator 1.14 1.23

Price Performance

Historical Comparison
GPCR
MC

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. It generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States, followed by Europe and the rest of the World.

Share on Social Networks: